CLINICAL_TRIALS
trial_result
· 2022-01-12
Clinical Trial Update: Intranasal Ketorolac Versus Intravenous Ketorolac for Treatment of Migraine Headaches in Children [Phase 3]
Summary
Phase 3 trial comparing intranasal ketorolac to intravenous ketorolac for treating migraine in children has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Columbia University | Conditions: Migraine | Phase 3 | Status: COMPLETED | Results posted: 2022-01-12